Navigation Links
Globus Medical's INDEPENDENCE(TM) Spacer System: The MILDER(TM) ALIF Solution
Date:2/26/2009

AUDUBON, Pa., Feb. 26 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced the full launch of its INDEPENDENCE(TM) Spacer System which is designed to provide a MILDER(TM) Anterior Lumbar Interbody Fusion (ALIF).

INDEPENDENCE(TM) integrates a stabilization plate and a PEEK interbody spacer into a preassembled, easy-to-use system that enables a less disruptive surgery than a traditional ALIF procedure. The entire procedure is streamlined by low profile instrumentation which facilitates a less invasive approach through a smaller incision.

The elimination of a traditional plate preserves the natural anatomic profile of a patient's lumbar spine. INDEPENDENCE(TM) also incorporates a smooth screw blocking mechanism minimizing the disruption to the anatomy surrounding the surgical site and may lessen the long term impact from surgery.

Dr. Ali Mortazavi, an Orthopaedic Spine Surgeon with Resurgens Orthopaedics in Atlanta, Ga. said, "INDEPENDENCE(TM) allows me to provide a less invasive procedure to my patients and reduces long term issues with the great (blood) vessels while still allowing the advantages of a traditional ALIF procedure. I have found the instrumentation expedites the entire procedure and allows me to deliver a better overall solution for patients."

MILDER(TM) - the Natural Evolution of Spine Care

The INDEPENDENCE(TM) Spacer is the latest addition to Globus Medical's MILDER(TM) Spine Care portfolio. The MILDER(TM) (Minimally Invasive, Less Disruptive, Earlier Recovery) Spine Care encompasses a holistic approach to spine care that integrates minimally invasive surgical techniques with implants, instrumentation, and education designed to lessen the disruption to a patient's anatomic structures and natural range of motion in order to facilitate an earlier, pain-free recovery.

"Our design goal was to provide a MILDER(TM) ALIF solution and deliver a simple, repeatable procedure with an implant that is anatomically matched to a broad range of patients," said Mark Adams, Group Engineering Manager of Interbody Fusion. He continues, "The entire INDEPENDENCE(TM) system including the unique low profile instruments streamlines an ALIF procedure while disrupting as little anatomy as possible."

About Globus Medical, Inc.

Globus Medical, Inc. is the largest privately held spinal implant manufacturer in the world and is based in Audubon, Pa. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders. Additional information can be accessed at www.globusmedical.com.


'/>"/>
SOURCE Globus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Globus Medical Announces Record 2nd Quarter 2007 Results
2. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. World Debut for BSPs HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008
5. SciQuest Announces Strategic Alliance with Ceiba Solutions
6. Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
7. Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314
8. Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs
9. Gene-engineered flies are pest solution
10. BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter
11. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology:
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOGĀ“s multi-biometrics system.   Continue ... ...
(Date:3/16/2017)... HANOVER, Germany , March 16, 2017 CeBIT 2017 - Against ... Continue Reading ... Used combined in one project, multi-biometric solutions ... ... Identification Systems) ...
Breaking Biology News(10 mins):